About shionogi & co. ltd. - SGIOF
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
SGIOF At a Glance
Shionogi & Co., Ltd.
3-1-8 Dosho-machi
Osaka, Osaka 541-0045
| Phone | 81-6-6202-2161 | Revenue | 2.87B | |
| Industry | Pharmaceuticals: Major | Net Income | 1.12B | |
| Sector | Health Technology | Employees | 4,955 | |
| Fiscal Year-end | 03 / 2026 | |||
| View SEC Filings |
SGIOF Valuation
| P/E Current | 14.032 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 11.428 |
| Price to Sales Ratio | 4.446 |
| Price to Book Ratio | 1.403 |
| Price to Cash Flow Ratio | 9.97 |
| Enterprise Value to EBITDA | 8.794 |
| Enterprise Value to Sales | 3.626 |
| Total Debt to Enterprise Value | 0.014 |
SGIOF Efficiency
| Revenue/Employee | 580,186.514 |
| Income Per Employee | 225,623.382 |
| Receivables Turnover | 3.566 |
| Total Asset Turnover | 0.293 |
SGIOF Liquidity
| Current Ratio | 6.635 |
| Quick Ratio | 6.129 |
| Cash Ratio | 2.897 |
SGIOF Profitability
| Gross Margin | 83.385 |
| Operating Margin | 36.457 |
| Pretax Margin | 45.981 |
| Net Margin | 38.888 |
| Return on Assets | 11.391 |
| Return on Equity | 12.947 |
| Return on Total Capital | 12.081 |
| Return on Invested Capital | 12.813 |
SGIOF Capital Structure
| Total Debt to Total Equity | 1.607 |
| Total Debt to Total Capital | 1.581 |
| Total Debt to Total Assets | 1.425 |
| Long-Term Debt to Equity | 1.352 |
| Long-Term Debt to Total Capital | 1.331 |